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Background
Few studies, if any, of hepatitis B (HBV), hepatitis C
(HCV) and HIV co-infections in pregnant women in Zam-
bia have been undertaken. HBV, HCV and HIV share at
least one common route of infection: blood to blood con-
tact through various transmission modalities.
Objective
In this study, the researcher attempted to evaluate the
prevalence of HBV and HCV co-infections among HIV
positive pregnant women.
Method
Ninety-seven HIV positive pregnant women (not yet on
HAART) admitted to mostly labor ward were clinically
examined and had their case files reviewed. They were also
on PMTCT program for HIV. HBV surface antigens and
anti-HCV antibodies were checked using ELISA. Informa-
tion concerning their HIV status was obtained from the
case files and antenatal cards.
Results
• HCV antibody seroprevalence was 4.1%(4/97), while
the prevalence of HBV was found to be 9.3%(9/
97).86.6%(84/97) of the cases had only HIV infection
• Those with HBV/HCV co-infection tended to be older
(age range 26–37 years), and all were black women three
quarters of whom had poor socio-economic status
• 38.5% of those with co-infection reported having had a
sexually transmitted infection (STI)
• Only 9.3% of all the cases had done their CD4 counts.
Those with HBV had an average CD4 of 350 cells/ml; HCV
with 417 cells/ml, and those without co-infection with
271 cells/ml.
Conclusion
• HBV/HCV co-infection in HIV is common (usually
under-diagnosed in this country)
• Co-infection with HBV/HCV/HIV seems to be associated
with older age
• Difficult to assess if co-infection with HBV/HCV has
impact on CD4 count because most subjects cannot afford
expensive CD4 measurements in this country
• HBV/HCV/HIV co-infection may pose serious chal-
lenges to success of HAART in this country with limited
resources
• A more comprehensive study is needed to elucidate the
full extent of this problem in the general population
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